Results 1 to 22 of 22
Thread: Test and Winny effects
-
06-11-2010, 12:43 PM #1Associate Member
- Join Date
- Jan 2007
- Location
- North East England
- Posts
- 479
Test and Winny effects
-
06-11-2010, 12:48 PM #2
Neither anavar nor winny cut fat.
-
06-11-2010, 12:50 PM #3
The best way to understand how they work, you should read up on each in the profiles section.
-
06-11-2010, 12:50 PM #4
-
06-11-2010, 01:02 PM #5
If they reduce fat mass (FM) they "cut fat".
As does Test Enan and the majority of other steroids .
Even in seditary individuals, FFM/LBM increases, FM is reduced, strength increases in untrained subjects.
Given AAS, subjects tend to loose more FM than other subjects not on AAS. Thats "cutting fat" to you and me.
-
06-11-2010, 01:04 PM #6
Yes but if someone takes those compounds and eats crappy or does't work out then they won`t cut fat.
-
06-11-2010, 01:12 PM #7
"Crappy food", yeah ok.
"Not workout" is seditary.
-
06-11-2010, 01:26 PM #8
Anavar (Oxandrolone) and Test Enan (untrained):
Int J Obes Relat Metab Disord. 1995 Sep;19(9):614-24.
Oral anabolic steroid treatment, but not parenteral androgen treatment, decreases abdominal fat in obese, older men.
Lovejoy JC, Bray GA, Greeson CS, Klemperer M, Morris J, Partington C, Tulley R.
Pennington Biomedical Research Center, Baton Rouge, Louisiana 70808-4124, USA.
Abstract
OBJECTIVE: To compare the effects of testosterone enanthate (TE), anabolic steroid (AS) or placebo (PL) on regional fat distribution and health risk factors in obese middle-aged men undergoing weight loss by dietary means. DESIGN: Randomized, double-blind, placebo-controlled clinical trial, carried out for 9 months with primary assessments at 3 month intervals. Due to adverse blood lipid changes, the AS group was switched from oral oxandrolone (ASOX) to parenteral nandrolone decaoate (ASND) after the 3 month assessment point. SUBJECTS: Thirty healthy, obese men, aged 40-60 years, with serum testosterone (T) levels in the low-normal range (2-5 ng/mL). MAIN OUTCOME MEASURES: Abdominal fat distribution and thigh muscle volume by CT scan, body composition by dual energy X-ray absorptiometry (DEXA), insulin sensitivity by the Minimal Model method, blood lipids, blood chemistry, blood pressure, thyroid hormones and urological parameters. RESULTS: After 3 months, there was a significantly greater decrease in subcutaneous (SQ) abdominal fat in the ASOX group compared to the TE and PL groups although body weight changes did not differ by treatment group. There was also a tendency for the ASOX group to exhibit greater losses in visceral fat, and the absolute level of visceral fat in this group was significantly lower at 3 months than in the TE and PL groups. There were significant main effects of treatment at 3 months on serum T and free T (increased in the TE group and decreased in the ASOX group) and on thyroid hormone parameters (T4 and T3 resin uptake significantly decreased in the ASOX group compared with the other two groups). There was a significant decrease in HDL-C, and increase in LDL-C in the ASOX group, which led to their being switched to the parenteral nandrolone decanoate (ASND) after 3 months. ASND had opposite effects on visceral fat from ASOX, producing a significant increase from 3 to 9 months while continuing to decrease SQ abdominal fat. ASND treatment also decreased thigh muscle area, while ASOX treatment increased high muscle. ASND reversed the effects of ASOX on lipoproteins and thyroid hormones. The previously reported effect of T to decrease visceral fat was not observed, in fact, visceral fat in the TE group increased slightly from 3 to 9 months, although SQ fat continued to decrease. Neither TE nor AS treatment resulted in any change in urologic parameters. CONCLUSIONS: Oral oxandrolone decreased SQ abdominal fat more than TE or weight loss alone and also tended to produce favorable changes in visceral fat. TE and ASND injections given every 2 weeks had similar effects to weight loss alone on regional body fat. Most of the beneficial effects observed on metabolic and cardiovascular risk factors were due to weight loss per se. These results suggest that SQ and visceral abdominal fat can be independently modulated by androgens and that at least some anabolic steroids are capable of influencing abdominal fat.
PMID: 8574271 [PubMed - indexed for MEDLINE]
-
06-11-2010, 01:31 PM #9
More on Anavar :
J Clin Endocrinol Metab. 2004 Oct;89(10):4863-72.
Effects of androgen therapy on adipose tissue and metabolism in older men.
Schroeder ET, Zheng L, Ong MD, Martinez C, Flores C, Stewart Y, Azen C, Sattler FR.
Department of Medicine and Division of Infectious Diseases, University of Southern California, Los Angeles, California 90033, USA.
Abstract
We investigated the effects of oxandrolone on regional fat compartments and markers of metabolism. Thirty-two 60- to 87-yr-old men (body mass index, 28.1 +/- 3.4 kg/m(2)) were randomized to oxandrolone (20 mg/d; n = 20) or matching placebo (n = 12) treatment for 12 wk. Oxandrolone reduced total (-1.8 +/- 1.0 kg; P < 0.001), trunk (-1.2 +/- 0.6 kg; P < 0.001), and appendicular (-0.6 +/- 0.6 kg; P < 0.001) fat, as determined by dual energy x-ray absorptiometry. The changes in total and trunk fat were greater (P < 0.001) than the changes with placebo. By magnetic resonance imaging, visceral adipose tissue decreased (-20.9 +/- 12 cm(2); P < 0.001), abdominal sc adipose tissue (SAT) declined (-10.7 +/- 12.1 cm(2); P = 0.043), the ratio VAT/SAT declined from 0.57 +/- 0.23 to 0.49 +/- 0.19 (P = 0.002), and proximal and distal thigh SC fat declined [-8.3 +/- 6.7 cm(2) (P < 0.001) and -2.2 +/- 3.0 kg (P = 0.004), respectively]. Changes in proximal and distal thigh SC fat with oxandrolone were different than with placebo (P = 0.018 and P = 0.059). A marker of insulin sensitivity (quantitative insulin sensitivity check index) improved with oxandrolone by 0.0041 +/- 0.0071 (P = 0.018) at study wk 12. Changes in total fat, abdominal SAT, and proximal extremity SC fat were correlated with changes in fasting insulin from baseline to study wk 12 (r >or= 0.45; P < 0.05). Losses of total fat and SAT were greater in men with baseline testosterone of 10.4 nmol/liter or less (<or= 300 ng/dl) than in those with higher levels [-2.5 +/- 1.1 vs. -1.5 +/- 0.8 kg (P = 0.036) and -24.1 +/- 14.3 vs. -2.9 +/- 21.3 cm(2) (P = 0.03), respectively]. Twelve weeks after discontinuing oxandrolone, 83% of the reductions in total, trunk, and extremity fat by dual energy x-ray absorptiometry scanning were sustained (P < 0.02). Androgen therapy, therefore, produced significant and durable reductions in regional abdominal and peripheral adipose tissue that were associated with improvements in estimates of insulin sensitivity. However, high-density lipoprotein cholesterol decreased by -0.49 +/- 0.21 mmol/liter and directly measured low-density lipoprotein cholesterol increased by 0.57 +/- 0.67 mmol/liter and non-high-density lipoprotein cholesterol increased by 0.54 +/- 0.97 mmol/liter (P < 0.03 for each) during treatment with oxandrolone; these changes were largely reversible. Thus, therapy with an androgen that does not adversely affect lipids may be beneficial for some components of the metabolic syndrome in overweight older men with low testosterone levels .
PMID: 15472177 [PubMed - indexed for MEDLINE]
Saying that "steroids dont burn fat", is parrotted garbage. I see it everyday.
No offence mate.
-
06-11-2010, 01:39 PM #10Saying that "steroids dont burn fat", is parrotted garbage. I see it everyday.
-
06-11-2010, 02:06 PM #11
Wrong. Read the studies again.
The first study is in "untrained subjects/individuals".
To quote, "Oral oxandrolone decreased SQ abdominal fat more than TE or weight loss alone and also tended to produce favorable changes in visceral fat."
"After 3 months, there was a significantly greater decrease in subcutaneous (SQ) abdominal fat in the ASOX group..."
What dont you understand about Anavar or other steroids burning fat (FM, VC, SF) in an untrained state? You could be sitting there watching the World Cup and the androgens would be "burning fat".
-
06-11-2010, 02:07 PM #12
when i am using mast i swear i can just chill and burn fat ha
-
06-11-2010, 02:08 PM #13
The burn fat trained or untrained.
You could be a fat c*nt and take AAS and lose MORE weight (FM, VC, SF) that someone else not using AAS on the same diet.
I'm not suggesting that by all means, but to say they "dont burn fat" is plain wrong and in contradiction with clinical data on the subject.
-
06-11-2010, 03:01 PM #14Wrong. Read the studies again.
-
06-11-2010, 03:02 PM #15
hahaha swiftos point is that they would of gained more fat if they didnt take gear.
-
06-11-2010, 03:07 PM #16
Actually, the other one is untrained aswell.
Its not rocket surgery (see what I did there...).
2 identical people on the same diet, one takes AAS. The one on AAS loses more FM than the one not on AAS. Therfore, AAS burn fat, or reduce fat mass (FM). Thats the last time I'm saying it.
I'm glad someone understands.
-
06-11-2010, 03:09 PM #17hahaha swiftos point is that they would of gained more fat if they didnt take gear.
-
06-11-2010, 03:10 PM #18I'm glad someone understands.
-
06-11-2010, 03:16 PM #19
Redz, c'mon.
Your clutching at f*cking straws now mate. I'm not here to get into an argument with you, nor am I here to belittle you in any way/shape/form.
I'm meerly disagreeing with you and stating why, then proving my opinoin with data (like I always do).
Their both peer-reviewed double blind controlled studies. Their not done by supplement companies selling a certain product. This is getting ridiculas.
Read my bold statement in the post I made before this. Apettite, lathergy are irrelevant.
-
06-11-2010, 03:18 PM #20
I think that in most cases the result will be fat loss but to say the compounds will do that is simply not always true.
-
06-11-2010, 03:20 PM #21
The studies arnt done on "2 people" either. There done on 62 subjects (32 + 30).
One study was done for "9 months".
Honestly, if you cant interpret the data and want to cherry pick what it says be my guest.
Your wrong, accept it.
Who gives a shit.
When I'm wrong I learn something. I'm constantly learning everyday.
-
06-11-2010, 03:20 PM #22
smoke dope and rap....agree to disagree.
Thread Information
Users Browsing this Thread
There are currently 1 users browsing this thread. (0 members and 1 guests)
Expired dbol (blue hearts)
01-11-2025, 04:00 PM in ANABOLIC STEROIDS - QUESTIONS & ANSWERS